Droxidopa Capsule
FDA Label NDC 70771-1610

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Droxidopa (NDC 70771-1610). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1609-9

Droxidopa Capsules, 100 mg

90 Capsules

Rx only

Droxi-100mg-image (1f3d60f8 B73c 459f 8f63 8cd6169a6431 01)

Droxi-100mg-image (1f3d60f8 B73c 459f 8f63 8cd6169a6431 01)

NDC 70771-1610-9

Droxidopa Capsules, 200 mg

90 Capsules

Rx only

Droxi-200mg-image (1f3d60f8 B73c 459f 8f63 8cd6169a6431 02)

Droxi-200mg-image (1f3d60f8 B73c 459f 8f63 8cd6169a6431 02)

NDC 70771-1611-9

Droxidopa Capsules, 300 mg

90 Capsules

Rx only

Droxi-300mg-image (1f3d60f8 B73c 459f 8f63 8cd6169a6431 03)

Droxi-300mg-image (1f3d60f8 B73c 459f 8f63 8cd6169a6431 03)

* Please review the disclaimer below.